Long-Term Tetrahydrobiopterin Treatment in PKU Patients of 0-18 Years - Study on Phenylalanine Tolerance and Safety
Clinical trial NCT00432822 · TERMINATED
Trial details
- NCT number
- NCT00432822
- Sponsor
- Orphanetics Pharma Entwicklungs GmbH
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.